Antitumor Effects of PRMT5 Inhibition in Sarcomas

Patients with advanced soft-tissue sarcomas (STS) have few therapeutic options. Protein arginine methyltransferase 5 (PRMT5), an anticancer target, has been extensively investigated in recent years in epithelial tumors. To date, no data related to the biological role of PRMT5 inhibition and its pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Verbeke, Stéphanie, Bourdon, Aurélien, Guegan, Jean-Philippe, Leroy, Laura, Chaire, Vanessa, Richard, Elodie, Bessede, Alban, Italiano, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621483/
https://www.ncbi.nlm.nih.gov/pubmed/37861293
http://dx.doi.org/10.1158/2767-9764.CRC-23-0239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621483/
https://www.ncbi.nlm.nih.gov/pubmed/37861293
http://dx.doi.org/10.1158/2767-9764.CRC-23-0239

Ejemplares similares